Ocular melanosis

From WikiMD's Medical Encyclopedia

Revision as of 05:05, 6 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Ocular melanosis
Synonyms Congenital melanosis oculi, melanosis bulbi
Pronounce N/A
Specialty N/A
Symptoms Increased pigmentation of the sclera and uvea
Complications Potential development of glaucoma, uveitis, or ocular melanoma
Onset Congenital or acquired
Duration Lifelong
Types N/A
Causes Genetic factors, primary acquired melanosis
Risks Increased risk of melanoma
Diagnosis Clinical examination, slit lamp examination
Differential diagnosis Nevus of Ota, ocular melanocytosis
Prevention N/A
Treatment Monitoring, laser therapy, surgical intervention if necessary
Medication N/A
Prognosis Variable, depending on complications
Frequency Rare
Deaths N/A


A condition characterized by increased pigmentation in the eye


Ocular melanosis is a condition characterized by increased pigmentation in the eye, particularly affecting the conjunctiva and uvea. This condition can be congenital or acquired and is often associated with other ocular or systemic conditions.

Pathophysiology[edit]

Ocular melanosis involves the proliferation of melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes. In the eye, melanocytes are normally present in the uvea, which includes the iris, ciliary body, and choroid. In ocular melanosis, there is an abnormal increase in the number of melanocytes or an increase in melanin production.

Types[edit]

Ocular melanosis can be classified into several types based on its origin and clinical presentation:

Congenital Ocular Melanosis[edit]

Congenital ocular melanosis is present at birth and may be associated with other congenital conditions such as nevus of Ota or Sturge-Weber syndrome. It is characterized by diffuse pigmentation of the uveal tract and sometimes the sclera.

Primary Acquired Melanosis (PAM)[edit]

Primary acquired melanosis is a condition that occurs later in life, typically in middle-aged or older adults. It presents as flat, brown patches on the conjunctiva and can be unilateral or bilateral. PAM is considered a precursor to conjunctival melanoma, a malignant tumor of the conjunctiva.

Clinical Features[edit]

Patients with ocular melanosis may present with visible pigmentation of the eye, which can vary in color from light brown to dark brown or even black. The pigmentation is usually flat and can be diffuse or localized. In some cases, patients may experience visual disturbances if the pigmentation affects the cornea or retina.

Diagnosis[edit]

Diagnosis of ocular melanosis is primarily clinical, based on the appearance of the pigmentation. However, additional tests such as slit-lamp examination, ultrasound biomicroscopy, and optical coherence tomography may be used to assess the extent of the pigmentation and to rule out other conditions such as melanoma.

Management[edit]

The management of ocular melanosis depends on the type and extent of the condition. Regular monitoring is essential, especially for primary acquired melanosis, due to the risk of progression to melanoma. In some cases, surgical excision or laser therapy may be considered to remove suspicious lesions.

Prognosis[edit]

The prognosis for ocular melanosis varies. Congenital forms are generally benign, while primary acquired melanosis requires careful monitoring due to the potential for malignant transformation.

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.